Author

Thomas G. Davies

Astex PharmaceuticalsORCID 0000-0002-1143-7289Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Assay:CRISPR screen· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:protein sequence· 1 Approach:transformer / foundation model· 1

Frequent Co-Authors

Marcel L. VerdonkiD· 2 shared Alex Watterson· 1 shared Barbara Abreu· 1 shared Benoît BaillifiD· 1 shared Cansu DinçeriD· 1 shared Carl R. PoelkingiD· 1 shared Emre KarakoçiD· 1 shared Gabriele PiccoiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Marcel L. VerdonkORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsbioRxivPreprintSep 14, 2026

Structure-function analysis of PI3K signalling cascade base editing screens in cancer cells

Katrina McCarten, Barbara Abreu, Benoît Baillif…·Mathew J. Garnett

The paper uses CRISPR base editing and structural analysis to identify functional residues in the PI3K pathway, revealing potential drug targets and allosteric pockets.

DOI 10.64898/2026.09.08.748517

humanCRISPR screen

𝕏 PostBluesky

BiochemistryBioinformaticsPeer-reviewedJun 1, 2025

Mapping the space of protein binding sites with sequence-based protein language models

Tuğçe Oruç, Maria Kadukova, Thomas G. Davies…·Carl R. Poelking

The paper develops a method combining protein language models with 3D tesselation to create detailed binding site representations, improving downstream tasks like druggability modeling and benchmarking.

4 citations

protein sequencedeep learning

𝕏 PostBluesky